JPRN-UMIN000016485Completed未知
Pilot study about imaging method of 18F-fluoro-dopa and 11C-raclopride in Parkinson's disease and Parkinson's syndrome - PD-1
Institute of Biomedical Research and Innovation0 sites20 target enrollmentStarted: February 9, 2015Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 20
Study Overview
Brief Summary
Published in Ann Nucl Med 2017; 31:163-171,
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 35years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Subjects who consciousness is not clear Subjects with cerebrovascular disorder Subjects with cardiac dysfunction Subjects with QT prolongation and ventricular arrhythmias on the electrocardiogram Subjects with liver and kidney failure Subjects with gastric ulcer and duodenal ulcer Subjects with diabetes Subjects with serious lung disease, bronchial asthma and endocrine disease Subjects with angle-closure glaucoma and chronic open-angle glaucoma Subjects who are psychiatric symptoms such as suicidal tendencies Subjects who are taking non-selective monoamine oxidase inhibitors Subjects who suffer from the symptomatic parkinsonism by clear organic cause Subjects who have the history of drug allergy Subjects who it is difficult to skip Parkinson treatment medicine from the day before Subjects with rhabdomyolysis Subjects with malignant syndrome Subjects with pheochromocytoma Subjects with prolactin-secreting pituitary tumor Subjects who are dehydration and malnutrition state Subjects Who exhibit a strong response to drink Subjects who are drug dependence, alcohol dependence Subjects who have participated in clinical research within the past 3 months Subjects who reserchers judged as inappropriate
Investigators
Similar Trials
Terminated
Early Phase 1
18F-FES PET/CT in Imaging Patients With Desmoid TumorsDeep Fibromatosis/Desmoid TumorFamilial Adenomatous PolyposisNCT02374931Vanderbilt-Ingram Cancer Center3
Completed
Not Applicable
Study to Calculate the Radiation Dosimetry in Subjects With Head and Neck CancerHead and Neck CancerNCT00245349University of Iowa9
Completed
Early Phase 1
Pilot Study to Evaluate 18F-fluorodeoxyglucose (FDG) Positron Emission Tomography /Computed Tomography (PET/CT) in Prediction of Early Response to Chemotherapy in Ovarian Cancer.Ovarian CancerNCT00620243Memorial Sloan Kettering Cancer Center9
Active, not recruiting
Phase 2
A Radiotracer ([18F]FluorThanatrace) by PET/CT for the Imaging of Breast CancerBreast CarcinomaNCT05226663M.D. Anderson Cancer Center36
Recruiting
Phase 1
Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTFBreast CarcinomaOvarian CarcinomaRecurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal CarcinomaSolid NeoplasmFallopian Tube CarcinomaPrimary Peritoneal CarcinomaNCT03604315M.D. Anderson Cancer Center300